Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.19.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Retained Earnings/ (Accumulated Deficit)
Total
Balance at Beginning at Oct. 31, 2017
Balance at Beginning (in shares) at Oct. 31, 2017      
Issuance of Founder Shares to Sponsor [1] $ 201 24,799 25,000
Issuance of Founder Shares to Sponsor (in shares) [1] 2,012,500      
Net income/Loss (1,025) (1,025)
Balance at Ending at Jun. 30, 2018 $ 201 24,799 (1,025) $ 23,975
Balance at Ending (in shares) at Jun. 30, 2018 2,012,500     2,012,500
Sale of 7,000,000 Units, net of underwriting discounts $ 700 69,215,734 $ 69,216,434
Sale of 7,000,000 Units, net of underwriting discounts (in shares) 7,000,000      
Sale of 2,900,000 Private Placement Warrants 1,160,000 1,160,000
Forfeiture of Founders Shares $ (26) 26
Forfeiture of Founders Shares (in shares) (262,500)      
Common stock subject to possible redemption $ (651) (65,747,162) (65,747,813)
Common stock subject to possible redemption (in shares) (6,510,243)      
Net income/Loss 347,407 347,407
Balance at Ending at Jun. 30, 2019 $ 224 $ 4,653,397 $ 346,382 $ 5,000,003
Balance at Ending (in shares) at Jun. 30, 2019 2,239,757     2,239,757
[1] Included an aggregate of 262,500 shares that were subject to forfeiture to the extent that the underwriters' over-allotment option was not exercised in full (see Note 7).